F

Fluicell AB
STO:FLUI

Watchlist Manager
Fluicell AB
STO:FLUI
Watchlist
Price: 10.5 SEK 2.94% Market Closed
Market Cap: 14.4m SEK

Net Margin
Fluicell AB

-367.7%
Current
-840%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-367.7%
=
Net Income
-9.9m
/
Revenue
2.7m

Net Margin Across Competitors

No Stocks Found

Fluicell AB
Glance View

Market Cap
14.4m SEK
Industry
Health Care

Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2018-04-18. The company commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.

FLUI Intrinsic Value
114.52 SEK
Undervaluation 91%
Intrinsic Value
Price
F
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-367.7%
=
Net Income
-9.9m
/
Revenue
2.7m
What is the Net Margin of Fluicell AB?

Based on Fluicell AB's most recent financial statements, the company has Net Margin of -367.7%.

Back to Top